Nuclear factor κb-dependent anti-inflammatory effects of s-allyl cysteine and s -propyl cysteine in kidney of diabetic mice

Journal of Agricultural and Food Chemistry

Volumn 60, Issue 12, 2012, Pages 3158-3165

  Mong, Mei Chin ^a   Yin, Mei Chin ^a,b  

^a ASIA UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

diabetes; MAPK; NF B; PPAR; s allyl cysteine; s propyl cysteine

Indexed keywords

ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY EFFECTS; BLOOD UREA; CYCLOOXYGENASE 2; DIABETIC MICE; HIGH DOSE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN-6; KIDNEY DISEASE; MAPK; MITOGEN ACTIVATED PROTEIN KINASE; MRNA EXPRESSION; NUCLEAR FACTORS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; PPAR; PROSTAGLANDINE; PROTEIN EXPRESSIONS; PROTEIN KINASE C; PROTEIN LEVEL; PROTEIN PRODUCTION; REACTIVE OXYGEN SPECIES; S-ALLYL CYSTEINE; S-PROPYL CYSTEINES; TUMOR NECROSIS FACTORS;

CYTOLOGY; DRUG PRODUCTS; MAMMALS; MEDICAL PROBLEMS; NITRIC OXIDE; PROTEINS;

AMINO ACIDS;

ANTIINFLAMMATORY AGENT; CYSTEINE; CYTOKINE; DRUG DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; PROSTAGLANDIN E2; REACTIVE OXYGEN METABOLITE; S ALLYLCYSTEINE; S PROPYLCYSTEINE; S-ALLYLCYSTEINE; S-PROPYLCYSTEINE;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CHEMISTRY; DIABETIC NEPHROPATHY; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; KIDNEY; MALE; METABOLISM; MOUSE; PHYSIOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CYSTEINE; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DINOPROSTONE; KIDNEY; MALE; MICE; MICE, INBRED BALB C; NF-KAPPA B; NITRIC OXIDE; REACTIVE OXYGEN SPECIES;

MUS;

EID: 84859119720     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf3002685     Document Type: Article

References (34)

1. Schena, F. P.; Gesualdo, L. Pathogenetic mechanisms of diabetic nephropathy J. Am. Soc. Nephrol. 2005, 1, 30-33
2. Brownlee, M. Biochemistry and molecular cell biology of diabetic complications Nature (London) 2001, 414, 813-820
3. Strippoli, G. F.; Di Paolo, S.; Cincione, R.; Di Palma, A. M.; Teutonico, A.; Grandaliano, G.; Schena, F. P.; Gesualdo, L. Clinical and therapeutic aspects of diabetic nephropathy J. Nephrol. 2003, 16, 487-499
4. Taslipinar, A.; Yaman, H.; Yilmaz, M. I.; Demirbas, S.; Saglam, M.; Taslipinar, M. Y.; Agilli, M.; Kurt, Y. G.; Sonmez, A.; Azal, O.; Bolu, E.; Yenicesu, M.; Kutlu, M. The relationship between inflammation, endothelial dysfunction and proteinuria in patients with diabetic nephropathy Scand. J. Clin. Lab. Invest. 2011, 71, 606-612
5. Matoba, K.; Kawanami, D.; Ishizawa, S.; Kanazawa, Y.; Yokota, T.; Utsunomiya, K. Rho-kinase mediates TNF-α-induced MCP-1 expression via p38 MAPK signaling pathway in mesangial cells Biochem. Biophys. Res. Commun. 2010, 402, 725-730
6. Ohga, S.; Shikata, K.; Yozai, K.; Okada, S.; Ogawa, D.; Usui, H.; Wada, J.; Shikata, Y.; Makino, H. Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation Am. J. Physiol. Renal Physiol. 2007, 292, 1141-1150
7. Toyoda, M.; Suzuki, D.; Honma, M.; Uehara, G.; Sakai, T.; Umezono, T.; Sakai, H. High expression of PKC-MAPK pathway mRNAs correlates with glomerular lesions in human diabetic nephropathy Kidney Int. 2004, 66, 1107-1114
8. Ramanan, S.; Kooshki, M.; Zhao, W.; Hsu, F. C.; Robbins, M. E. PPARalpha ligands inhibit radiation-induced microglial inflammatory responses by negatively regulating NF-kappaB and AP-1 pathways Free Radical Biol. Med. 2008, 45, 1695-1704
9. Tang, S. C.; Leung, J. C.; Chan, L. Y.; Tsang, A. W.; Lai, K. N. Activation of tubular epithelial cells in diabetic nephropathy and the role of the peroxisome proliferator-activated receptor-gamma agonist J. Am. Soc. Nephrol. 2006, 17, 1633-1643
10. Fukushima, S.; Takada, N.; Hori, T.; Wanibuchi, H. Cancer prevention by organosulfur compounds from garlic and onion J. Cell. Biochem. 1997, 27, 100-105
11. Jones, M. G.; Hughes, J.; Tregova, A.; Milne, J.; Tomsett, A. B.; Collin, H. A. Biosynthesis of the flavour precursors of onion and garlic J. Exp. Bot. 2004, 55, 1903-1918
12. Hsu, C. C.; Yen, H. F.; Yin, M. C.; Tsai, C. M. Five cysteine-containing compounds delay diabetic deterioration in Balb/cA mice J. Nutr. 2004, 134, 3245-3249
13. Hsu, C. C.; Lin, C. C.; Liao, T. S.; Yin, M. C. Protective effect of s-allyl cysteine and s-propyl cysteine on acetaminophen-induced hepatotoxicity in mice Food Chem. Toxicol. 2006, 44, 393-397
14. Tsai, S. J.; Chiu, C. P.; Yang, H. T.; Yin, M. C. s-Allyl cysteine, s-ethyl cysteine, and s-propyl cysteine alleviate β-amyloid, glycative, and oxidative injury in brain of mice treated by D-galactose J. Agric. Food Chem. 2011, 59, 6319-6326
15. Kim, K. M.; Chun, S. B.; Koo, M. S.; Choi, W. J.; Kim, T. W.; Kwon, Y. G.; Chung, H. T.; Billiar, T. R.; Kim, Y. M. Differential regulation of NO availability from macrophages and endothelial cells by the garlic component S-allyl cysteine Free Radical Biol. Med. 2001, 30, 747-756
16. Lowry, O. H.; Rosebrough, N. J.; Farr, A. L. Protein determination with the Folin phenol reagent J. Biol. Chem. 1951, 193, 265-275
17. Gupta, R.; Dubey, D. K.; Kannan, G. M.; Flora, S. J. S. Concomitant administration of Moringa oleifera seed powder in the remediation of arsenic-induced oxidative stress in mouse Cell Biol. Int. 2007, 31, 44-56
18. Sutherland, B. A.; Shaw, O. M.; Clarkson, A. N.; Jackson, D. N.; Sammut, I. A.; Appleton, I. Neuroprotective effects of (-)-epigallocatechin gallate following hypoxia-ischemia-induced brain damage: novel mechanisms of action FASEB J. 2005, 19, 258-260
19. Koya, D.; Haneda, M.; Nakagawa, H.; Isshiki, K.; Sato, H.; Maeda, S.; Sugimoto, T.; Yasuda, H.; Kashiwagi, A.; Ways, D. K.; King, G. L.; Kikkawa, R. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes FASEB J. 2000, 14, 439-447
20. Yuan, H.; Lanting, L.; Xu, Z. G.; Li, S. L.; Swiderski, P.; Putta, S.; Jonnalagadda, M.; Kato, M.; Natarajan, R. Effects of cholesterol-tagged small interfering RNAs targeting 12/15-lipoxygenase on parameters of diabetic nephropathy in a mouse model of type 1 diabetes Am. J. Physiol. Renal Physiol. 2008, 295, F605-F617
21. Forbes, J. M.; Fukami, K.; Cooper, M. E. Diabetic nephropathy: Where hemodynamics meets metabolism Exp. Clin. Endocrinol. Diabetes 2007, 115, 69-84
22. Zhao, Y.; Banerjee, S.; LeJeune, W. S.; Choudhary, S.; Tilton, R. G. NF-κB-inducing kinase increases renal tubule epithelial inflammation associated with diabetes Exp. Diabetes Res. 2011, 192564
23. Chen, S. R.; Xu, X. Z.; Wang, Y. H.; Chen, J. W.; Xu, S. W.; Gu, L. Q.; Liu, P. Q. Icariin derivative inhibits inflammation through suppression of p38 mitogen-activated protein kinase and nuclear factor-kappaB pathways Biol. Pharm. Bull. 2010, 33, 1307-1313
24. Wong, C. K.; Ho, A. W.; Tong, P. C.; Yeung, C. Y.; Kong, A. P.; Lun, S. W.; Chan, J. C.; Lam, C. W. Aberrant activation profile of cytokines and mitogen-activated protein kinases in type 2 diabetic patients with nephropathy Clin. Exp. Immunol. 2007, 149, 123-131
25. Adhikary, L.; Chow, F.; Nikolic-Paterson, D. J.; Stambe, C.; Dowling, J.; Atkins, R. C.; Tesch, G. H. Abnormal p38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathy Diabetologia 2004, 47, 1210-1222
26. Kiritoshi, S.; Nishikawa, T.; Sonoda, K.; Kukidome, D.; Senokuchi, T.; Matsuo, T.; Matsumura, T.; Tokunaga, H.; Brownlee, M.; Araki, E. Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: Potential role in diabetic nephropathy Diabetes 2003, 52, 2570-2577
27. Sharma, K.; Danoff, T. M.; DePiero, A.; Ziyadeh, F. N. Enhanced expression of inducible nitric oxide synthase in murine macrophages and glomerular mesangial cells by elevated glucose levels: Possible mediation via protein kinase C Biochem. Biophys. Res. Commun. 1995, 207, 80-88
28. Noh, H.; King, G. L. The role of protein kinase C activation in diabetic nephropathy Kidney Int. Suppl. 2007, 106, 49-53
29. Kumar, A.; Hawkins, K. S.; Hannan, M. A.; Ganz, M. B. Activation of PKC-beta(I) in glomerular mesangial cells is associated with specific NF-kappaB subunit translocation Am. J. Physiol. Renal Physiol. 2001, 281, 613-619
30. Duan, S. Z.; Usher, M. G.; Mortensen, R. M. PPARs: The vasculature, inflammation and hypertension Curr. Opin. Nephrol. Hypertens. 2009, 18, 128-133
31. Vijay, S. K.; Mishra, M.; Kumar, H.; Tripathi, K. Effect of pioglitazone and rosiglitazone on mediators of endothelial dysfunction, markers of angiogenesis and inflammatory cytokines in type-2 diabetes Acta Diabetol. 2009, 46, 27-33
32. Cheng, C. F.; Chen, H. H.; Lin, H. Role of PPARα and its agonist in renal diseases PPAR Res. 2010, 345098
33. Cariou, B.; Zaï, Y.; Staels, B.; Bruckert, E. Effects of the new dual PPAR α/δ agonist GFT505 on lipid and glucose homeostasis in abdominally obese patients with combined dyslipidemia or impaired glucose metabolism Diabetes Care 2011, 34, 2008-2014
34. Krest, I.; Glodek, J.; Keusgen, M. Cysteine sulfoxides and alliinase activity of some Allium species J. Agric. Food Chem. 2000, 48, 3753-3760